Characterization of learning and memory behaviors and the effects of metrifonate in the C57BL strain of mice

European Journal of Pharmacology

Volumn 372, Issue 2, 1999, Pages 117-126

  Ikonen, Sami ^a   Schmidt, Bernard H ^a   Riekkinen Jr , Paavo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; C57BL; Hippocampus lesion; Medial septum; Metrifonate; Mouse; Spatial navigation

Indexed keywords

METRIFONATE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN INJURY; COGNITION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEPTUM NUCLEUS; SPATIAL MEMORY;

ANIMALS; AVOIDANCE LEARNING; CHOLINESTERASE INHIBITORS; FEMALE; HIPPOCAMPUS; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; TRICHLORFON;

EID: 0033048440     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00203-4     Document Type: Article

References (18)

1. Cummings, J.L., Cyrus, P.A., Gulanski, B., 1998. Metrifonate efficacy in the treatment of psychiatric and behavioral disturbances of Alzheimer's disease patients. Abstracts of the 1998 Annual Scientific Meeting of the American Geriatrics Society/American Federation for Aging Research, poster #P196.
2. Eagger S., Morant N., Levy R., Sahakian B. Tacrine in Alzheimer's disease. Time course of changes in cognitive function and practice effects. Br. J. Psychiatry. 160:1992;36-40.
3. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F.et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 373:1995;523-527.
4. Hagan, J.J., Morris, R.G.M., 1988. The cholinergic hypothesis of memory: a review of animal experiments. In: Iversen, L.L., Iversen, S.D., Snyder, S.H., (Eds.), Psychopharmacology of the Aging Nervous System. Plenum, New York, pp. 237-323.
5. Hedreen J.C., Bacon S.J., Price D.L. A modified histochemical technique to visualize acetylcholinesterase-containing axons. J. Histochem. Cytochem. 33:1985;134-140.
6. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
7. Ikonen S., Schmidt B., Riekkinen P. Jr. Apamin improves spatial navigation in medial septal-lesioned mice. Eur. J. Pharmacol. 347:1998;13-21.
8. Mori F., Cuadra G., Giacobini E. Metrifonate effects on acetylcholine and biogenic amines in rat cortex. Neurochem. Res. 20:1995;1081-1088.
9. Morris R.G., Garrud P., Rawlins J.N., Keefe O. Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
10. Morris J.C., Cyrus P.A., Orazem J., Mas J., Bieber F., Ruzicka B.B., Gulanski B. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease. Neurology. 50:1998;1222-1230.
11. Nalbantoglu J., Tirado Santiago G., Lahsaini A., Poirier J., Goncalves O., Verge G., Momoli F., Welner S.A., Massicotte G., Julien J.P., Shapiro M.L. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature. 387:1997;500-505.
12. Riekkinen P. Jr., Soininen H., Helkala E.L., Partanen K., Laakso M., Vanhanen M., Riekkinen P. Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease. NeuroReport. 6:1995;1297-1300.
13. Riekkinen P. Jr., Schmidt B., Stefanski R., Kuitunen J., Riekkinen M. Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats. Eur. J. Pharmacol. 309:1996;121-130.
14. Riekkinen P. Jr., Schmidt B., Riekkinen M. Behavioral characterization of metrifonate-improved acquisition of spatial information in medial septum-lesioned rats. Eur. J. Pharmacol. 323:1997;11-19.
15. Riekkinen M., Soininen H., Riekkinen P. Sr., Kuikka J., Laakso M., Helkala E.L., Partanen J., Riekkinen P. Jr. Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease. Neuroscience. 83:1998;471-479.
16. Scali C., Giovannini M.G., Bartolini L., Prosperi C., Hinz V., Schmidt B., Pepeu G. Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats. Eur. J. Pharmacol. 325:1997;173-180.
17. Schmidt, B.H., Hinz, V.C., van der Staay, F.J., 1997. Cognition enhancement by metrifonate: evidence from animal studies. In: Iqbal, K., Winblad, B., Nishimura, T., Takeda, M., Wisniewski, H.M. (Eds.), Alzheimer's Disease: Biology, Diagnosis and Therapeutics. Wiley, Chicester, pp. 781-786.
18. Schmidt, B.H., Hinz, V.C., van der Staay, F.J., 1998. The preclinical pharmacology of metrifonate, a long-acting and well-tolerated cholinesterase inhibitor for Alzheimer therapy. In: Fisher, A., Yoshida, M., Hanin, I. (Eds.), Progress in Alzheimer's and Parkinson's Diseases, Vol. 49. Plenum, New York, pp. 579-585.